10:00am PDT - July 22nd, 2023
The #FDA approves AstraZeneca and Sanofi’s #Nirsevimab, a game-changer against respiratory syncytial virus. This single-shot solution, effective & safe, has the potential to protect all infants against RSV. A monumental step forward, but questions about cost coverage remain. #RSV https://t.co/chBRkc3nx8
0 retweets 0 likes - Gergely Szótér (@GergelySzoter)